Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity.
about
Advanced techniques using contrast media in neuroimagingOptimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomasMagnetic resonance perfusion imaging in neuro-oncology.Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data.Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Contrast Leakage Patterns from Dynamic Susceptibility Contrast Perfusion MRI in the Grading of Primary Pediatric Brain Tumors.Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerAnalysis of dynamic contrast enhanced MRI.Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survivalComparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors.Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.Assessment of Blood-Brain Barrier Permeability by Dynamic Contrast-Enhanced MRI in Transient Middle Cerebral Artery Occlusion Model after Localized Brain Cooling in RatsBlood-brain barrier permeability of normal-appearing white matter in patients with vestibular schwannoma: A new hybrid approach for analysis of T1 -W DCE-MRI.Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas.Arterial input function and gray matter cerebral blood volume measurements in children.Is Weisskoff model valid for the correction of contrast agent extravasation with combined T1 and T2* effects in dynamic susceptibility contrast MRI?Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma.Perfusion magnetic resonance imaging in pediatric brain tumors.Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation.Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma.Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.Signal intensity in T2' magnetic resonance imaging is related to brain glioma grade.Imaging microvascular structure with contrast enhanced MRI.Parametric mapping of scaled fitting error in dynamic susceptibility contrast enhanced MR perfusion imaging.Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas.Correction of T1 Effects in Calculation of Relative Recirculation in Ischemic Stroke Patients
P2860
Q22252349-F1392C3C-5C23-40F8-8FA9-95FBB9099AECQ30419061-5BFEC81F-F135-4BA0-843D-7FE2EDE7B694Q30479156-D16AD5F8-D010-454E-AF8C-E040D01DF71DQ30770588-A03CDA4C-453E-435C-AC75-0D08EF638CAAQ30818733-9777BFBB-FD5E-43CB-B333-68079C5087BBQ30907831-A223A143-7552-4976-9E8D-A78BAC293827Q31022764-6AA2639D-FD7F-46B0-B3C1-D57A53762F52Q31101076-1428BFA9-C1BC-47DB-85D6-D7BF63756ECCQ34538659-909BFAF0-E5BC-4F9C-8A80-5D4D63E717AEQ36022692-410E3F11-CA74-4C98-B21E-C5F3E1B5622AQ36048166-666AE3B7-C1B9-4A70-A9D2-4696BB5AE0FBQ36120153-802B915D-9B63-483A-85B6-5F67D13D6DB2Q36378153-60B0A174-F676-43DF-8E1F-2CBD71EB5374Q37223115-B311F02E-D805-4B5B-96C1-41882F42A729Q39002038-FF7CDC78-F77B-4161-AF8D-334982BC08C7Q39051829-74B3C6E1-160B-425C-A28D-D4E5591A33FAQ40378982-2678763F-993E-49D5-AA04-D727BEB33A14Q43673888-9E939B19-C440-4D0C-893E-680E2E328EE3Q45051419-A01C119F-A12D-4B56-A60D-4249C75FAA98Q48113208-BCDE4C85-4D4F-4CFF-BE3D-DE720D58F740Q48131174-12F74521-5018-4AB9-ADD8-69124C91D541Q48289741-7E4D6FEF-C6E8-4ADE-97FA-0B9380B2FA1CQ48342333-52C6D2AE-ACAD-4090-A6E7-853C2C1D91BEQ51495475-0C48F63C-669D-419F-A971-91002C92985EQ51533240-E9373840-0FD8-4A01-89F9-8DF7E76AC980Q51573923-66CA0A09-28B2-4B79-993A-2E5DA4A7DFECQ52076698-E8DAB1F6-A75B-4004-9A13-92381F1CD15DQ52091201-56C213D1-2DB5-454A-B7A5-7D2F13EEF225Q55473889-40FD55A3-37C9-4A97-B806-42DBAB0F74DFQ56909072-ECD03A0C-5FE0-4C5A-955E-18986A71CB1F
P2860
Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Abnormalities of the contrast ...... marker of vascular tortuosity.
@en
Abnormalities of the contrast ...... marker of vascular tortuosity.
@nl
type
label
Abnormalities of the contrast ...... marker of vascular tortuosity.
@en
Abnormalities of the contrast ...... marker of vascular tortuosity.
@nl
prefLabel
Abnormalities of the contrast ...... marker of vascular tortuosity.
@en
Abnormalities of the contrast ...... marker of vascular tortuosity.
@nl
P2093
P2860
P1476
Abnormalities of the contrast ...... marker of vascular tortuosity.
@en
P2093
Annesley DJ
Kamaly-Asl ID
P2860
P304
P356
10.1002/(SICI)1522-2586(200002)11:2<103::AID-JMRI5>3.0.CO;2-Z
P577
2000-02-01T00:00:00Z